Subtopic Deep Dive
GDF15 and Inflammation Pathways
Research Guide
What is GDF15 and Inflammation Pathways?
GDF15 modulates inflammation pathways as a stress-responsive cytokine expressed in macrophages and endothelial cells, exerting anti-inflammatory effects via TGF-β superfamily signaling in sepsis and autoimmune conditions.
GDF15, also known as MIC-1, rises in response to inflammatory stress in cardiomyocytes, adipocytes, and macrophages (Adela and Banerjee, 2015, 454 citations). It functions as a novel immune checkpoint inhibiting macrophage activity (Wischhusen et al., 2020, 452 citations). Over 20 papers from the provided lists link GDF15 to inflammation in cachexia, cardiovascular disease, and mortality prediction.
Why It Matters
GDF15 elevation correlates with inflammation-driven muscle wasting in cachexia, offering a biomarker for monitoring chronic inflammatory diseases (Webster et al., 2020). In cardiovascular contexts, GDF15 predicts mortality risk independently in older adults and heart failure patients (Daniels et al., 2011; Tromp et al., 2018). Targeting GDF15 as an immune checkpoint holds potential for therapies in sepsis and cytokine storms (Wischhusen et al., 2020).
Key Research Challenges
Dissecting Cell-Specific Expression
GDF15 expression varies across macrophages, cardiomyocytes, and epithelia under stress, complicating pathway attribution (Adela and Banerjee, 2015). Studies struggle to isolate inflammation-specific induction from general stress responses (Zimmers et al., 2005). Over 10 papers highlight inconsistent tissue sources in disease models.
Mechanisms of Anti-Inflammatory Action
GDF15 inhibits inflammation via Smad signaling, but exact downstream effectors in autoimmune diseases remain unclear (Wischhusen et al., 2020). Contradictory roles emerge in cachexia versus protective sepsis responses (Webster et al., 2020). Citation analysis shows unresolved debates in 452-cited reviews.
Translational Biomarker Validation
Elevated GDF15 predicts mortality in inflammation-linked conditions, yet causality versus correlation persists (Wiklund et al., 2010, 273 citations). Clinical trials lack frameworks for geroscience-guided validation (Justice et al., 2018). Papers note gaps in longitudinal data for autoimmune applications.
Essential Papers
GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective
Ramu Adela, S. Banerjee · 2015 · Journal of Diabetes Research · 454 citations
Growth differentiation factor-15 (GDF-15) is a stress responsive cytokine. It is highly expressed in cardiomyocytes, adipocytes, macrophages, endothelial cells, and vascular smooth muscle cells in ...
Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint
Jörg Wischhusen, Ignacio Melero, Wolf H. Fridman · 2020 · Frontiers in Immunology · 452 citations
Growth/differentiation factor-15 (GDF-15), also named macrophage inhibitory cytokine-1, is a divergent member of the transforming growth factor β superfamily. While physiological expression is bare...
Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis
Hyo Kyun Chung, Dongryeol Ryu, Koon Soon Kim et al. · 2016 · The Journal of Cell Biology · 337 citations
Reduced mitochondrial electron transport chain activity promotes longevity and improves energy homeostasis via cell-autonomous and –non-autonomous factors in multiple model systems. This mitohormet...
Inflammation and Skeletal Muscle Wasting During Cachexia
Justine Webster, Laura JAP Kempen, Rowan Hardy et al. · 2020 · Frontiers in Physiology · 305 citations
Cachexia is the involuntary loss of muscle and adipose tissue that strongly affects mortality and treatment efficacy in patients with cancer or chronic inflammatory disease. Currently, no specific ...
A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME Biomarkers Workgroup
Jamie N. Justice, Luigi Ferrucci, Anne B. Newman et al. · 2018 · GeroScience · 301 citations
Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction
Jasper Tromp, B. Daan Westenbrink, Wouter Ouwerkerk et al. · 2018 · Journal of the American College of Cardiology · 288 citations
Macrophage inhibitory cytokine‐1 (MIC‐1/GDF15): a new marker of all‐cause mortality
Fredrik Wiklund, Anna M. Bennet, Patrik K. E. Magnusson et al. · 2010 · Aging Cell · 273 citations
Summary Macrophage inhibitory cytokine‐1 (MIC‐1/GDF15) is a member of the TGF‐b superfamily, previously studied in cancer and inflammation. In addition to regulating body weight, MIC‐1/GDF15 may be...
Reading Guide
Foundational Papers
Start with Wiklund et al. (2010, 273 citations) for GDF15 as inflammation mortality marker and Bauskin et al. (2006, 249 citations) for TGF-β cytokine roles in pathogenesis.
Recent Advances
Study Wischhusen et al. (2020, 452 citations) on immune checkpoint functions and Webster et al. (2020, 305 citations) on cachexia inflammation.
Core Methods
Core techniques include ELISA for GDF15 levels, Smad signaling assays, macrophage inhibition studies, and longitudinal biomarker cohorts (Adela and Banerjee, 2015; Daniels et al., 2011).
How PapersFlow Helps You Research GDF15 and Inflammation Pathways
Discover & Search
Research Agent uses searchPapers and exaSearch to find GDF15 inflammation papers like 'GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases' by Adela and Banerjee (2015), then citationGraph reveals 454 downstream citations linking to cachexia and sepsis. findSimilarPapers expands to macrophage-specific studies from Wischhusen et al. (2020).
Analyze & Verify
Analysis Agent applies readPaperContent to extract Smad signaling details from Wischhusen et al. (2020), verifies claims with CoVe against Wiklund et al. (2010), and runs PythonAnalysis on citation data for statistical trends in inflammation biomarkers using pandas. GRADE grading scores evidence strength for GDF15's anti-inflammatory role in macrophages.
Synthesize & Write
Synthesis Agent detects gaps in cell-specific GDF15 expression across Adela (2015) and Webster (2020), flags contradictions in pro- versus anti-inflammatory effects, and generates exportMermaid diagrams of pathways. Writing Agent uses latexEditText, latexSyncCitations for 10+ papers, and latexCompile to produce review sections on inflammation modulation.
Use Cases
"Extract and plot GDF15 expression levels from inflammation datasets in provided papers."
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas/matplotlib on Adela 2015 data) → plot of macrophage vs epithelial expression trends.
"Draft LaTeX review on GDF15 in sepsis inflammation pathways."
Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Wischhusen 2020, Webster 2020) → latexCompile → formatted PDF section.
"Find GitHub repos analyzing GDF15 biomarker data from inflammation studies."
Research Agent → paperExtractUrls (Daniels 2011) → paperFindGithubRepo → githubRepoInspect → curated list of analysis scripts for mortality prediction models.
Automated Workflows
Deep Research workflow scans 50+ GDF15 papers via searchPapers, structures inflammation pathway reports with GRADE scoring from Wiklund (2010) and Adela (2015). DeepScan applies 7-step CoVe checkpoints to verify anti-inflammatory claims in cachexia (Webster 2020). Theorizer generates hypotheses on Smad signaling gaps from Wischhusen (2020) citationGraph.
Frequently Asked Questions
What defines GDF15's role in inflammation pathways?
GDF15 acts as a stress-induced cytokine from macrophages inhibiting immune responses via TGF-β signaling (Adela and Banerjee, 2015; Wischhusen et al., 2020).
What methods study GDF15-inflammation links?
Researchers use biomarker assays in sepsis models, Smad pathway inhibition, and macrophage cultures (Zimmers et al., 2005; Webster et al., 2020).
What are key papers on GDF15 and inflammation?
Top papers include Adela and Banerjee (2015, 454 citations) on expression in inflammatory cells and Wischhusen et al. (2020, 452 citations) on immune checkpoint functions.
What open problems exist in GDF15 inflammation research?
Challenges include causal mechanisms in autoimmunity, tissue-specific effects, and trial validation beyond correlation (Justice et al., 2018; Tromp et al., 2018).
Research GDF15 and Related Biomarkers with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching GDF15 and Inflammation Pathways with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the GDF15 and Related Biomarkers Research Guide